Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is expected to experience strong growth in the coming years due to its position as a leader in the breast and body-shaping implant market, along with positive financial projections and a "Buy" rating from analysts. However, potential risks such as economic downturn and competition should not be overlooked. Additionally, investors should monitor the company's ability to generate positive free cash flow by the second half of 2026 as it works towards its goal of profitability.

Bears say

Establishment Labs Hldgs is seeing growth in their product sales and adoption, primarily due to increasing demand and utilization of their Motiva implants by plastic surgeons. Despite a recent pullback in shares, the company has a strong potential for long-term revenue growth and free cash flow. However, risks such as economic downturns, competition, and potential complications in the treated population should be considered. Their recent submission for a Motiva label expansion for breast reconstruction also shows potential for future growth, but this may require additional expenses dedicated towards supporting this indication.

ESTA has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Strong Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Strong Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.